New Zealand markets closed

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6500-0.3300 (-8.29%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.18M
Enterprise value 56.58M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.25
Price/book (mrq)1.11
Enterprise value/revenue 2.30
Enterprise value/EBITDA -0.63

Trading information

Stock price history

Beta (5Y monthly) 1.76
52-week change 3-87.00%
S&P500 52-week change 322.55%
52-week high 331.5000
52-week low 33.0250
50-day moving average 34.5913
200-day moving average 38.8197

Share statistics

Avg vol (3-month) 328.68k
Avg vol (10-day) 330.47k
Shares outstanding 51.68M
Implied shares outstanding 61.68M
Float 8521.78k
% held by insiders 137.68%
% held by institutions 136.74%
Shares short (14 Jun 2024) 456.87k
Short ratio (14 Jun 2024) 41.47
Short % of float (14 Jun 2024) 418.00%
Short % of shares outstanding (14 Jun 2024) 43.38%
Shares short (prior month 15 May 2024) 417.51k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:18
Last split date 309 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -183.66%
Operating margin (ttm)-247.70%

Management effectiveness

Return on assets (ttm)-26.81%
Return on equity (ttm)-155.29%

Income statement

Revenue (ttm)24.63M
Revenue per share (ttm)14.80
Quarterly revenue growth (yoy)-45.50%
Gross profit (ttm)N/A
EBITDA -30.27M
Net income avi to common (ttm)-47.13M
Diluted EPS (ttm)-28.2900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.6M
Total cash per share (mrq)9.27
Total debt (mrq)36.12M
Total debt/equity (mrq)166.83%
Current ratio (mrq)3.65
Book value per share (mrq)-4.93

Cash flow statement

Operating cash flow (ttm)-26.74M
Levered free cash flow (ttm)-17.67M